down arrow

Krebs Biochem

3
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE268B01013
  • NSEID: KREBSBIO
  • BSEID: 524518
INR
73.81
2.81 (3.96%)
BSENSE

Apr 11, 12:16 PM

BSE+NSE Vol: 2.64 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is -3.29% vs -12.68% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 44.72% vs 53.58% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 57.72% vs -44.85% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 20.10% vs 44.55% in Mar 2023

Compare Profit and Loss Results of Krebs Biochem
Markets Mojo
Figures in Rs cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
50.00
9,264.00
-9,214.00
-99.46%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
50.00
9,264.00
-9,214.00
-99.46%
Expenditure (Ex Depriciation)
Stock Adjustments
1.00
-25.00
26.00
104.00%
Raw Materials Consumed
5.00
2,933.00
-2,928.00
-99.83%
Power & Fuel Cost
22.00
70.00
-48.00
-68.57%
Employee Cost
16.00
1,982.00
-1,966.00
-99.19%
Operating Expenses
9.00
143.00
-134.00
-93.71%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
806.00
-806.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
136.00
-136.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
59.00
6,939.00
-6,880.00
-99.15%
Operating Profit (PBDIT) excl Other Income
-8.00
2,325.00
-2,333.00
-100.34%
Other Income
0.00
266.00
-266.00
-100.00%
Operating Profit (PBDIT)
-8.00
2,592.00
-2,600.00
-100.31%
Interest
4.00
15.00
-11.00
-73.33%
Profit before Depriciation and Tax
-12.00
2,577.00
-2,589.00
-100.47%
Depreciation
6.00
317.00
-311.00
-98.11%
Profit Before Taxation & Exceptional Items
-19.00
2,259.00
-2,278.00
-100.84%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-19.00
2,259.00
-2,278.00
-100.84%
Provision for Tax
0.00
436.00
-436.00
-100.00%
Profit After Tax
-19.00
1,823.00
-1,842.00
-101.04%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-250.00
7,868.00
-8,118.00
-103.18%
Profit Available for appropriations
-270.00
9,691.00
-9,961.00
-102.79%
Appropriations
-270.00
9,691.00
-9,961.00
-102.79%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-9.16
45.52
-54.68
-120.12%
Profit And Loss - Net Sales
Net Sales 50.42 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -3.29% vs -12.68% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -8.72 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 44.72% vs 53.58% in Mar 2023

Profit And Loss - Interest
Interest 4.69 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 57.72% vs -44.85% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax -19.73 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 20.10% vs 44.55% in Mar 2023